More than six months into the pandemic, we know that wearing a mask is essential for slowing the spread of COVID-19. The AMA speaks with physicians about the 6 things they wish their patients knew about masks.
September 24, 2020
Whether it’s a natural disaster, a data breach, the loss of a key physician, or COVID-19, a crisis presents an unsettling circumstance to any leader. Crisis management is a “evergreen” topic for physician leaders. Always preparing for (and learning from) a crisis presents an opportunity for leaders to thrive. Successful physician leaders prepare their teams, put communications in place, and shore up their systems to manage the situation at hand.
In this SoundPractice episode, we talk with Max Reibolt, CPA, president and CEO of The Coker Group, about the characteristics, communication skills, and organizational support leaders need during a crisis. Max shares examples from his many decades of healthcare leadership and consulting.
September 23, 2020
Featuring articles on a RAS oncogene inhibitor at last, avelumab maintenance therapy in bladder cancer, lower-dose zinc for childhood diarrhea, antisense oligonucleotides for hereditary angioedema, and sussing out the sestrins; a review article on congenital adrenal hyperplasia due to 21-hydroxylase deficiency; a case report of a man with sudden cardiac arrest; and Perspective articles on competing visions for the future of health policy, on assessing the safety of glucose-lowering drugs, on Ebola response priorities in the time of Covid-19, and on a farewell gift from a mother. Supplement to the New England Journal of Medicine, Vol. 383, No. 13.
September 23, 2020
Editor's Summary by Preeti Malani, MD, MSJ, Associate Editor of JAMA, the Journal of the American Medical Association, for the September 22, 2020 issue
September 22, 2020
During COVID-19, managing high-risk pregnancies has become even more complex. As part of Women in Medicine Month, we talk with experts about the challenges of pregnancy care during the pandemic.
September 17, 2020
Featuring articles on exome sequencing analysis in stillbirth, a two-year trial of belimumab in lupus nephritis, nocturnal oxygen in COPD, adjuvant targeted therapy in melanoma, and daratumumab in refractory lupus; a review article on immune tolerance; a case report of a man with fever and shortness of breath after liver transplantation; and Perspective articles on consent to trainee involvement in pediatric care, on examining examinations conducted under anesthesia, on June Medical Services v. Russo, and on sticks and stones. Supplement to the New England Journal of Medicine, Vol. 383, No. 12.
September 16, 2020
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the September 15, 2020 issue
September 15, 2020
Our understanding of COVID-19 evolves quickly. We discuss the latest research on vaccines, antibodies, and more with JAMA editor-in-chief Dr. Howard Bauchner.
September 10, 2020
Featuring articles on strategies for tracheostomy decannulation, extending factor VIII activity in hemophilia A, eflornithine–sulindac in familial adenomatous polyposis, darolutamide in castration-resistant prostate cancer, the NIH RADx initiative, and on training innate immunity; a review article on pharmacologic treatment of ADHD; a case report of a man with intrusive thoughts and fear of poisoning; and Perspective articles on health equity, on the cancer risk associated with lorcaserin, on whether Covid can catalyze an educational transformation, and on the ideal intern. Supplement to the New England Journal of Medicine, Vol. 383, No. 11.
September 9, 2020
You’ve probably heard stories from friends, family members, or colleagues who quit a job because of a toxic person - someone who belittles, humiliates, shames, or bullies others. Maybe you’ve even left a job because of such a person. Toxic employees not only take a toll on their coworkers’ emotional psyches but the financial outcomes of their organizations as well.
In this SoundPractice episode, Cheryl Toth digs into the issue of handling toxic team members and bosses with Mitchell Kusy, PhD., the author of Why I Don’t Work Here Anymore. Kusy is a professor in the Graduate School of Leadership and Change at Antioch University and an international consultant to leadership. He presents research, evidence-based tactics, and concrete examples of how to restore workplace civility and increase financial performance after toxic employees leave an organization. Dr. Kusy’s latest article will appear in the Sep/Oct issue of Physician Leadership Journal; link below.
“Six Intentional Ways to Build Teams of Everyday Civility (and Proactively Erode Toxic Behaviors)” Physician Leadership Journal
Why I Don’t Work Here Anymore
September 9, 2020
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the September 8, 2020 issue
September 8, 2020
This fall, more COVID-19 cases are expected, just in time for cold and flu season. As health systems and communities prepare, it's vital to look back at the tactics that succeeded earlier this year. We discuss lessons from Henry Ford Health System as they plan ahead.
September 3, 2020
Featuring articles on weight loss in underserved patients, the effect of phenylbutyrate–taurursodiol on ALS progression, tepotinib in lung cancer, capmatinib in MET-altered lung cancer, and reopening primary schools during the pandemic; a review article on pulmonary fibrotic diseases; a Clinical Problem-Solving describing a curve ball; and Perspective articles on progress in cancer research, prevention, and care; on public health decision making during Covid-19; on long-term care policy after Covid-19; and on the tragedy of measles. Supplement to the New England Journal of Medicine, Vol. 383, No. 10.
September 2, 2020
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the September 1, 2020 issue
September 1, 2020
As the pandemic continues, contract tracing is an important tool to track the spread of COVID-19. We speak with Marcus Plescia, MD, chief medical officer of the Association of State and Territorial Health Officials, about the progress of contract tracing in the U.S.
August 27, 2020
In this timely SoundPractice podcast interview, Mike Sacopulos interviews Nancy Collins, VP at the American Association for Physician Leadership about their flagship publication, the Physician Leadership Journal. They discuss the editorial mission of the PLJ, the mechanics of submitting an article, how the peer-review process works, and how the collaborative process with the PLJ editorial team is helping to build the next era of physician leader scholars.
PLJ article topics are these: Careers, Communication, Finance, Healthcare Organizations, Healthcare Professionals, Health Law and Policy, Innovation, Leadership, Management, Patient Care and Quality, Technology.
Bonus! Listen to the end for the inside scoop on what reviewers look for in a quality manuscript, and pitfalls to avoid in paper submissions to any medical journal.
Contact Information at [email protected]
Submission Guidelines and Policies for the PLJ: https://www.physicianleaders.org/news/author-submission-guidelines-for-the-physician-leadership-journal
Society for Scholarly Publishing – Useful information on journal publishing
Review a sample issue of the Physician Leadership Journal
August 26, 2020
Featuring articles on selpercatinib in RET fusion–positive lung cancer, selpercatinib for medullary thyroid cancer, a closed-loop system in children with type 1 diabetes, sticky findings in breast cancer, and reconsidering the use of race correction in clinical algorithms; a review article on atherosclerotic plaque healing; a case report of a woman with headache and gait imbalance; and Perspective articles on improving the quality of U.S. health care, on Covid-19 and immunity in aging populations, and on U.S. efforts to curb antibiotic resistance. Supplement to the New England Journal of Medicine, Vol. 383, No. 9.
August 26, 2020
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the August 25, 2020 issue
August 25, 2020
In the 100th episode of the AMA COVID-19 Update, Mira Irons, MD, shares details about new testing and a cautiously optimistic look at the latest numbers and trends.
August 20, 2020
Featuring articles on evinacumab for familial hypercholesterolemia, the effects of diet vs. gastric bypass in diabetes, drug-coated balloons for dysfunctional dialysis arteriovenous fistulas, fracture risk vs. fracture prevention with bisphosphonates, and the challenges of “return to work” in an ongoing pandemic; a review article on trigeminal neuralgia; a case report of a woman with altered mental status and weakness on the left side; and Perspective articles on low-threshold buprenorphine initiation, on when prescribing isn’t enough, on the death throes of Mercy, and on when the EMR stole a doctor’s pen. Supplement to the New England Journal of Medicine, Vol. 383, No. 8.
August 19, 2020
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the August 18, 2020 issue
August 18, 2020
As the U.S. continues to cope with COVID-19, opioid addiction and abuse continue to be a deadly problem. Join AMA immediate past president and chair of the AMA Opioid Taskforce, Patrice A Harris, MD, MA, and other addiction specialists as they discuss the nation's continued drug overdose epidemic. Subscribe to daily COVID video updates from the AMA at ama-assn.org/COVIDupdate
August 13, 2020
Featuring articles on azacitidine plus venetoclax in AML, compression for recurrent cellulitis of the leg, decreased population-based mortality from lung cancer, the United States and the WHO, the need for a tighter particulate-matter air-quality standard, and bilirubin in IBD and pancreatitis; a review article on epigenetic therapies for cancer; a case report of a woman with a lung mass; and Perspective articles on whether we spend too much on health care, on people with hepatitis C who inject drugs, on hepatitis C treatment in correctional facilities, and on a national medical response to crisis. Supplement to the New England Journal of Medicine, Vol. 383, No. 7.
August 12, 2020
Richard C. Boothman is an expert attorney specializing in the area of professional liability and litigation avoidance. His work on behalf of physicians and health systems has been nationally recognized. He has testified before the United States Senate on dispute resolution models and his work on the “Michigan Model” has influenced how many health systems handle professional liability claims. Join Mike Sacopulos and Rick Boothman for a deep dive into the principles of the “Michigan Model,” methods of reasoned and humane methods of handling medical malpractice, and a glimpse into legal and privacy issues surrounding the use of telehealth.
Richard C. BoothmanBoothman Consulting Group, LLC
Adjunct Assistant Professor, University of Michigan Medical School, Dept of Surgery
Visiting Scholar, Vanderbilt University Medical School, Center for Patient and Professional Advocacy
August 12, 2020